FDA Limits on Antibacterial Healthcare Ingredients Could Put Patients, Employee Safety at RiskRead More
Washington, DC, | August 13, 2014 – Analysis of research showing trace elements of antibacterial ingredients in pregnant women and fetuses...MoreRead More
Antibacterial Ingredients Play Beneficial Role in Hygiene and Health for Millions, FDA ToldRead More
Green group’s unscientific attack on soap June 18, 2014 | The Hill Newly proposed rules by the FDA could severely limit or even...MoreRead More
The American Cleaning Institute and the Personal Care Products Council filed detailed comments with the Food and Drug Administration asking for changes in proposed rules governing antibacterial soaps and ingredients. The groups said the FDA’s proposal could eliminate consumer access to these products and “would increase the risk and level of exposure of the general population to bacteria, which could lead to increased infection and disease.”Read More
A: Credible scientific data indicates that triclosan does not disrupt hormonal activity or function and there is extensive data that demonstrates that triclosan is neither genotoxic (harmful to genetic material) nor mutagenic (cause genetic mutation). As with other substances which are bodies are exposed to, the predominant route of excretion for triclosan is the urine. Therefore it would not be surprising to be able to measure triclosan in random urine samples from the population, as well as in other body fluids, such as breast milk.
ACI's DeLeo: loss of many healthcare antiseptic products would have serious public health implications.
- Wednesday Sep 3